期刊文献+

VEGF、MMP-2与TIMP-2在大肠癌中的表达 被引量:7

Study on the expression of the inhibitor of VEGF,MMP-2 and TIMP-2 in colorectal carcinoma
下载PDF
导出
摘要 目的 研究VEGF、MMP 2与TIMP 2在大肠癌组织中的表达、相互关系及与肿瘤生物学行为的相关性。方法 对 5 4例大肠癌患者的手术切除之癌组织和癌周正常组织 ,应用免疫组织化学方法检测其VEGF、基质金属蛋白酶MMP 2和组织金属蛋白酶抑制剂TIMP 2的表达情况 ,探讨两者之间的相互关系及其与肿瘤生物学行为的相关性。结果 VEGF、MMP 2与TIMP 2这三种蛋白在肿瘤组织中表达水平明显高于在正常组织中的表达。这三种蛋白的表达呈正相关 ,且表达水平与组织类型、组织分化程度、淋巴结转移、临床分期和五年生存率有统计学相关性 (P <0 .0 5 )。结论 大肠癌中VEGF、MMP 2与TIMP 2的表达 ,可能是癌肿发生、生长和浸润转移的重要因素 ,可作为判断肿瘤恶性程度的重要指标。 Objective To investigate the expression of VEGF, MMP-2 and TIMP-2 and the relationship between these three proteins, as well as the relationship between the expressions of these proteins and the biological behavior of carcinoma. Methods Immunohistochemical method was used to detect the expression of VEGF, MMP-2 and TIMP-2 in the carcinoma tissues and normal tissues around the foci. The relationship between these three proteins, together with the relationship between these proteins and the biological activity of carcinoma was further investigated. Results The expressions of VEGF and MMP-2 were high in carcinoma tissues while low in normal tissues. As for P33 ING1 , the case is to the contrary. There is correlation between the expressions of these proteins. And there is also statistical correlation between the expressions of these protein and the tissue type, tumor differentiation, metastasis of lymph node, Dukes stage, and five-year survival. Conclusion The high expressions of VEGF, MMP-2 and TIMP-2 in carcinoma increase may be important factors involved in carcinogenesis, development, invasion and metastasis, which can be used as predictors of malignant behavior of colorectal carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 2004年第1期21-23,共3页 Cancer Research on Prevention and Treatment
关键词 VEGF MMP-2 TIMP-2 大肠癌 基质金属蛋白酶 组织金属蛋白酶抑制剂 血管内皮生长因子 Colorectal carcinoma Vascular Endothelial Growth Factor(VEGF) matrix metalloproteinase-2(MMP-2) tissue inhibitor of metalloproteinnases(TIMP-2)
  • 相关文献

参考文献6

  • 1[1]Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growtg factor) and its receptor in adenocarcinomas of the gastrointestinal tract[J]. Cancer Res,1993,53(19):4727-4736.
  • 2[2]Evelyne D, Patricia H, Aude V, et al. Tumor angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model[J]. J Hepatol,2003,38(6):793-802.
  • 3[3]Murray GI. Matrix metaloproteinases: a multifunctional group of molecules[J]. J Pathol, 2001,195 (2):135-137.
  • 4[4]Loukopoulos P, Mungall BA, Straw RC, et al. Matrix metalloproteinase-2 and-9 involvement in canine tumors[J]. Vet Pathol,2003,40(4):382-394.
  • 5[5]Worley JR, Thompkins PB, Lee MH, et al. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1(MT1-MMP)[J]. Biochem J, 2003,372(3):799-809.
  • 6[6]Zucker S, Mirza H, Conner CE, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation[J].Int J Cancer,1998,75(5):780-786.

同被引文献124

引证文献7

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部